Medicare hospice benefit is the Part A-covered palliative care program available to beneficiaries who are certified by a physician as terminally ill with a life expectancy of 6 months or less if their illness runs its normal course. Electing hospice trades curative treatment for the terminal diagnosis for comprehensive comfort-focused care, and the coverage is more generous than most beneficiaries expect before they need it.
Key Takeaways
- Medicare hospice benefit is covered under Part A. The eligibility threshold is physician certification of a life expectancy of 6 months or less if the terminal illness runs its normal course.
- Hospice election trades curative treatment of the terminal diagnosis for comfort-focused palliative care. Curative treatment for unrelated conditions continues to be covered.
- Medicare Advantage beneficiaries who elect hospice receive hospice services through Original Medicare, not through their MA plan. This is a structural requirement under 42 CFR 422.320, not an optional benefit design.
- The benefit structure is two initial 90-day periods followed by unlimited 60-day periods. The beneficiary must be recertified as terminally ill at each transition. There is no dollar cap on the hospice benefit.
- Revocation is permitted at any time and takes effect immediately. A beneficiary who revokes hospice can return to curative treatment without waiting and can re-elect hospice later if still eligible.
What hospice election actually means
The hospice election is a formal decision, not a gradual transition. A beneficiary who elects Medicare hospice benefit signs a statement certifying that they understand they are giving up their Medicare coverage for curative treatment of the terminal diagnosis. That is the trade. It is not a permanent surrender of Medicare, and it is not a decision that affects coverage for conditions unrelated to the terminal illness.
The distinction between the terminal diagnosis and other conditions matters practically. A client with lung cancer who elects hospice continues to receive Medicare coverage for their diabetes management, their hypertension medications through Part D (for drugs unrelated to the terminal condition), and their orthopedic care. What stops is Medicare payment for chemotherapy, radiation, or other curative interventions targeting the lung cancer specifically.
Revocation is available at any time. The beneficiary signs a statement revoking the election, and the revocation is effective immediately. The benefit period they were in is used up, but they can return to curative treatment, re-enroll in their regular Medicare or Medicare Advantage benefits for the terminal condition, and re-elect hospice later if they still meet the eligibility standard. The benefit is not a one-way door.
Benefit periods and recertification
The benefit period structure is two initial 90-day periods, followed by unlimited 60-day periods. At the end of each benefit period, the hospice physician must recertify that the beneficiary remains terminally ill under the 6-month prognosis standard. If the beneficiary is recertified, the next period begins. If they are not, they are discharged from hospice.
There is no dollar cap on the Medicare hospice benefit. Medicare pays the hospice provider a daily rate covering all covered services for the benefit period. Four payment rates exist under Medicare's hospice payment system: routine home care (the most common, at roughly $220 per day in 2026 for days 1 through 60 and a lower rate thereafter), continuous home care (for periods of crisis requiring near-continuous nursing), inpatient respite care, and general inpatient care for pain and symptom management not manageable at home. The hospice provider bills Medicare at the applicable rate. The beneficiary pays only the limited cost-sharing described below.
What hospice covers and what it does not
| Service | Covered? | Notes |
|---|---|---|
| Nursing care | Yes | Skilled nursing and aide visits. 24/7 on-call availability is required from the hospice provider. |
| Physician services | Yes | The hospice medical director and attending physician services related to the terminal diagnosis. |
| Medications for comfort | Yes, with cost-sharing | Drugs for pain relief and symptom control related to the terminal diagnosis. The beneficiary pays a $5 copay per prescription or 5 percent of the Medicare-approved cost, whichever is less. |
| Durable medical equipment | Yes | Wheelchairs, hospital beds, oxygen, and other equipment related to comfort care. |
| Inpatient respite care | Yes, with cost-sharing | Up to 5 consecutive days per benefit period in an approved inpatient facility, to relieve family caregivers. The beneficiary pays 5 percent of the Medicare-approved inpatient respite care cost. |
| Social work, counseling, chaplain services | Yes | Included as core hospice services. Bereavement counseling for the family continues for up to 1 year after the patient's death. |
| Room and board | No (with exception) | Medicare does not pay room and board at a nursing facility or residential hospice. The exception is inpatient care medically necessary for pain or symptom management that cannot be achieved at home. |
| Curative treatment for the terminal diagnosis | No | Hospice election ends Medicare payment for curative treatment of the terminal condition. Treatment for unrelated diagnoses remains covered. |
Coverage summary based on Medicare hospice benefit rules effective for 2026. Actual payment rates and cost-sharing may change with annual CMS updates. Verify coverage specifics with the hospice provider.
Medicare Advantage and hospice: the coordination structure brokers must explain
This is the part most MA beneficiaries do not anticipate. Under 42 CFR 422.320, Medicare Advantage plans are required to provide hospice coverage, but they do not actually deliver it. All hospice services for an MA enrollee are provided through Original Medicare Part A. The beneficiary retains their MA plan during hospice for coverage of conditions unrelated to the terminal diagnosis, but the MA plan does not manage, authorize, or pay for any hospice-related services.
The practical implications: the MA plan's network restrictions do not apply to hospice providers. Prior authorization is not required for hospice-related services. The MA plan's cost-sharing structure does not apply to hospice costs. The beneficiary accesses any Medicare-certified hospice provider, not just those in the MA network.
What continues: the MA plan's premium. The beneficiary keeps paying their MA plan premium during hospice, even though Original Medicare is covering the hospice services. This is the nuance that catches clients off guard. Quotit's MA plan comparison tools, for example, do not surface this coordination structure in plan descriptions as of September 2026. The explanation falls to the broker at enrollment time.
There is also a Part D interaction. Once hospice is elected, the MA plan's drug coverage (if it has a Part D component) stops paying for medications related to the terminal diagnosis. The hospice provider covers those drugs under the daily payment rate. The beneficiary's Part D coverage continues only for prescriptions unrelated to the terminal condition.
The Medigap angle for Original Medicare enrollees
Beneficiaries enrolled in Original Medicare with a Medigap supplement have their hospice cost-sharing handled differently from MA enrollees. Medigap Plans A, B, C, D, F, G, K, L, M, and N all cover the Medicare Part A hospice coinsurance or copayment, including the respite care coinsurance. Plan G and Plan N enrollees have no out-of-pocket hospice cost-sharing beyond the drug copay structure (up to $5 per prescription for terminal-illness-related medications). This is one context where Plan N and Plan G provide substantively equivalent hospice cost protection.
For clients with Medicare Savings Programs, the QMB benefit covers Medicare cost-sharing including hospice copays. Clients who qualify for Medicare Extra Help (Low Income Subsidy) have their Part D drug copays reduced to zero, including any hospice drug cost-sharing that remains their responsibility under the program's structure.
The broker conversation: before the crisis, not during
The clients who have the most useful hospice conversations with their broker are those who have them before a diagnosis, not at the point of hospice election. A broker who raises the Medicare hospice benefit during the annual wellness review for a client managing a serious chronic condition, such as advanced COPD, congestive heart failure, or late-stage kidney disease, gives that client and their family time to understand the benefit, ask questions, and discuss preferences without the pressure of an active crisis.
The T65 marketing window is also a useful moment. Brokers who are already working with turning-65 clients on Medicare plan selection can include a brief explanation of the hospice benefit structure as part of the plan comparison. Clients who understand the MA hospice coordination rule before they enroll in an MA plan are better prepared to explain it to family members if the time comes.
To illustrate: a 72-year-old client in a Medicare Advantage PPO is diagnosed with stage IV pancreatic cancer in January. The oncologist certifies a prognosis of 3 to 4 months. The client elects hospice in March. The client's MA plan continues to cover diabetes management and blood pressure medications. The hospice provider, selected from any Medicare-certified agency in the county, covers all palliative care for the pancreatic cancer: nursing visits, pain medications, a hospital bed, and a wheelchair. Original Medicare Part A pays the hospice at the applicable daily rate. The MA plan premium of $0 to $30 per month continues to be deducted from the client's Social Security benefit. The client experiences no additional cost beyond the small drug copays.
Illustrative example. Actual Medicare hospice payment rates, cost-sharing, and MA plan structures depend on the specific plan and CMS annual updates.
Medicare hospice benefit: broker FAQ
Common questions brokers encounter when clients or families ask about Medicare hospice coverage.
What does 6 months or less mean for hospice eligibility, and what happens if the patient lives longer?
The 6-month certification reflects the physician's judgment that the illness, if it runs its normal course, would be expected to cause death within 6 months. It is a medical prognosis, not a guarantee. If a beneficiary outlives the initial benefit periods, they can continue to receive hospice as long as a physician recertifies at each benefit period transition that they remain terminally ill under this standard. There is no limit on the number of benefit periods. A beneficiary who improves enough that they no longer meet the 6-month standard would be discharged from hospice, though they can re-elect if their condition deteriorates again.
Does electing Medicare hospice affect Part D prescription drug coverage?
It does, for drugs related to the terminal diagnosis. Once hospice is elected, the hospice provider becomes responsible for covering medications related to comfort care for the terminal condition. The beneficiary's Part D plan is no longer the payer for those drugs. Part D coverage continues for prescriptions unrelated to the terminal diagnosis. Beneficiaries who were receiving Extra Help for Part D cost-sharing should verify with their hospice provider how drug coverage will be coordinated, since the $5 hospice copay structure replaces the Part D cost-sharing for terminal-illness drugs.
What is the Medicare Advantage hospice election rule, and why does it matter?
Under 42 CFR 422.320, Medicare Advantage plans must provide hospice benefits, but all hospice services are delivered through Original Medicare, not through the MA plan. When a beneficiary enrolled in an MA plan elects hospice, they retain their MA plan for coverage of conditions unrelated to the terminal diagnosis, but their hospice services are billed to and paid by Original Medicare Part A. This means the MA plan's network, referral requirements, and prior authorization rules do not apply to hospice care. What it also means is that the beneficiary's MA plan premium continues during hospice, even though Original Medicare is paying for the hospice services. Brokers should walk clients through this before enrollment so the coordination structure is not a surprise.
Can a beneficiary receive both hospice and palliative care at the same time?
Not through Medicare simultaneously, in most cases. Palliative care under Medicare is provided alongside curative treatment through regular Part A, Part B, and Part D coverage. Hospice replaces curative treatment for the terminal diagnosis with comfort-focused care. A beneficiary who wants curative treatment and palliative support can receive both before electing hospice, but once hospice is elected, Medicare stops covering curative treatment for the terminal condition. The two are separate Medicare pathways, not concurrent ones. Some private insurance plans and Medicaid programs allow concurrent palliative and curative care for certain diagnoses, but standard Medicare does not.
What is the broker's role in the hospice conversation with a client or family?
The broker's role is informational, not medical. Brokers who understand the hospice benefit structure can explain the coverage mechanics, the MA plan coordination rule, and the revocation option without steering a medical decision. The most common gap is clients who assume their MA plan will manage hospice the way it manages everything else, and are surprised to learn it routes through Original Medicare. The most useful contribution a broker makes in this context is raising the hospice benefit during the annual wellness review for clients with serious chronic conditions, well before a crisis, so the family has time to process the information without urgency.
